Berahyaluronidase Alfa and Pembrolizumab/Enfortumab Vedotin Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of berahyaluronidase alfa and pembrolizumab, and enfortumab vedotin that can be used for the treatment of bladder cancer.

**Synonyms:** - Berahyaluronidase Alfa and Pembrolizumab Plus Enfortumab Vedotin - Berahyaluronidase Alfa and Pembrolizumab-Enfortumab Vedotin - Berahyaluronidase Alfa-pmph and Pembrolizumab-Enfortumab Vedotin-ejfv - Berahyaluronidase Alfa-pmph and Pembrolizumab/Enfortumab Vedotin-ejfv Regimen - Enfortumab Vedotin Plus Pembrolizumab and Berahyaluronidase Alfa-pmph - Enfortumab Vedotin-Pembrolizumab and Berahyaluronidase Alfa - Enfortumab Vedotin-ejfv-Pembrolizumab and Berahyaluronidase Alfa-pmph - Enfortumab Vedotin-ejfv/Berahyaluronidase Alfa-pmph and Pembrolizumab - Keytruda Qlex/Padcev Regimen - Padcev/Keytruda Qlex Regimen - Pembrolizumab and Berahyaluronidase Alfa-pmph with Enfortumab Vedotin-ejfv - Pembrolizumab and Berahyaluronidase Alfa-pmph-Enfortumab Vedotin-ejfv - Pembrolizumab and Berahyaluronidase Alfa-pmph/Enfortumab Vedotin Regimen